ACCELERATE adoption of EXOSKELETONS for construction and manufacturing applications in the North Sea Region. (Q4294401)
Jump to navigation
Jump to search
Project Q4294401 in Belgium, Germany, United Kingdom, Netherlands, Sweden, Denmark
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ACCELERATE adoption of EXOSKELETONS for construction and manufacturing applications in the North Sea Region. |
Project Q4294401 in Belgium, Germany, United Kingdom, Netherlands, Sweden, Denmark |
Statements
1,917,670.0 Euro
0 references
3,835,345.0 Euro
0 references
50.0 percent
0 references
1 January 2020
0 references
30 June 2023
0 references
InnovationQuarter
0 references
57°0'50.36"N, 9°59'4.42"E
0 references
52°10'5.81"N, 4°29'12.55"E
0 references
51°31'18.44"N, 9°58'10.70"E
0 references
60°40'7.64"N, 17°7'6.49"E
0 references
52°4'44.51"N, 4°20'15.00"E
0 references
52°14'18.60"N, 6°51'27.29"E
0 references
55°55'26.33"N, 3°17'14.14"W
0 references
50°49'22.84"N, 4°23'33.47"E
0 references
50°51'38.56"N, 4°40'50.16"E
0 references
51°11'35.63"N, 3°11'2.65"E
0 references
51°32'7.40"N, 9°55'55.70"E
0 references
EU and NSR manufacturing and construction workers undertake physically strenuous activities increasing the risk of health problems, disability and sick leave, leading to lower job attractiveness and job candidate scarcity. The unfilled job openings slow growth and competitiveness especially as NSR SMEs are mostly unaware of available solutions via exoskeleton adoption (solution developers tend to currently focus on large corporates). EXSKALLERATE tackles these issues by focusing on accelerating the adoption of exoskeletons into construction and industrial manufacturing SMEs, where heavy physical work leads to severe health issues. Exoskeleton use could alleviate 10-40% of muscle peak loads for passive, and up to 80% for active exoskeletons. EXSKALLERATE contributes to SME competitiveness & occupational health by making NSR a leading exoskeleton ecosystem. The consortium of business support organisations, clusters, and research institutes, do this with 3 main activities: 1) Partners listen and identify SME challenges leading to the co-design of field labs where next generation exoskeletons integrate improvements. Improved exoskeleton benefits are validated in end-user pilots sites. 2) Informative workshops with SMEs and exoskeleton experts present and receive feedback on tools to support SME decision making in exoskeleton adoption, a key challenge limiting adoption. 3) Transnational benchmarking accelerates industrial exoskeleton standardisation (Needed for SME decision making). (English)
0 references